Skip to main content
Enovis CORP logo

Enovis CORP — Investor Relations & Filings

Ticker · ENOV ISIN · US1940142052 LEI · 635400OP2DYYYMOIYL17 US Manufacturing
Filings indexed 1,374 across all filing types
Latest filing 2015-06-16 Director's Dealing
Country US United States of America
Listing US ENOV

About Enovis CORP

https://www.enovis.com/

Enovis CORP is a global medical technology company focused on developing clinically differentiated solutions for musculoskeletal health. The company's portfolio addresses the continuum of care, from prevention and surgical intervention to rehabilitation. Its offerings include a wide range of products such as orthopedic bracing and supports, surgical implants for reconstructive joint surgeries, and technologies for bone growth stimulation and physical therapy. Through brands like DonJoy, Aircast, and Enovis Surgical, the company partners with healthcare professionals to improve patient outcomes and transform clinical workflows with its products, services, and integrated technologies.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2015-06-16 English
4 Filing
Director's Dealing
2015-06-16 English
8-K Filing
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 5, 2015, reporting the entry into a material definitive agreement, specifically a credit agreement involving a term loan and revolving credit facility. The content focuses on financing activities, including loan amounts, interest rates, covenants, and guarantees. There is no financial statement or earnings data presented, nor is it an announcement of a report publication. The primary subject is an update on the company's capital structure and financing arrangements. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is 5832 characters, sufficient to contain substantive details about the financing agreement rather than a brief announcement or certification.
2015-06-05 English
SD Filing
Regulatory Filings Classification · 95% confidence The document is a Form SD filed with the SEC, specifically a Specialized Disclosure Report related to conflict minerals for the calendar year ended December 31, 2014. It references Rule 13p-1 under the Securities Exchange Act and includes a Conflict Minerals Report as an exhibit. The document length is 2351 characters, which is relatively short and primarily serves as a disclosure filing rather than a full financial or management report. This type of filing is regulatory in nature and does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is a specialized regulatory disclosure filing, best classified under Regulatory Filings (RNS).
2015-06-01 English
4 Filing
Director's Dealing
2015-05-28 English
4 Filing
Director's Dealing
2015-05-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.